Jielin Li
Papers
1
Total Citations
107
H-Index
1
About
Jielin Li is a leading figure in urologic oncology, whose research has fundamentally shaped the surgical management of bladder cancer. Li is best known for pioneering high-level evidence in the comparative effectiveness of robot-assisted surgery, most notably through a landmark 2012 systematic review and meta-analysis comparing robot-assisted radical cystectomy (RARC) to open radical cystectomy (ORC). This seminal work, cited over 100 times, provided the first robust synthesis of early outcomes, demonstrating that while RARC reduces blood loss and hospital stay, it does not compromise oncologic efficacy—a finding that helped legitimize the robotic approach in major cancer centers worldwide. Beyond this meta-analysis, Li’s broader contributions span clinical outcomes research, surgical innovation, and the rigorous evaluation of minimally invasive techniques. With a citation impact that underscores their role as a trusted synthesizer of evidence, Li has empowered surgeons and patients to make data-driven decisions in a rapidly evolving field. Their work remains a cornerstone for ongoing trials and quality improvement initiatives in urologic surgery.
Research Focus
Key Achievements
Top Papers
- 1